Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-159

Absolutely, I have been invested in this for more than a decade, just as I was invested in Neuren for more than a decade. I saw the same scenario there as I see here now. I bought into NEU at $0.16 (adjusted for consolidation, $0.008 originally) and now they are about $20. My ave get in price here is probably about $0.05 The potential of Viroporins is easily equivalent to NEU’s technology. Today’s announcement said as much as it could without letting the cat out of the bag, but both paws and a big healthy tail are clearly visible… Keep the faith and get rich, the rabble will move their hustles elsewhere. Bats and pink cows are cool..